Technology
Results: 13405-13416 of 23682

Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection

Results: 13405-13416 of 23682

